(1 reference)-
- Target See all BCL10 Antibodies
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Reactivity
- Human
- Host
- Please inquire
-
Clonality
- Monoclonal
-
Conjugate
- This BCL10 antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Specificity
- Ni-NTA purified recombinant human BCL-10 expressed in E. Coli strain BL21 (DE3).
- Purification
- Antibodies are purified by protein A affinity chromatography
- Isotype
- IgG1
- Top Product
- Discover our top product BCL10 Primary Antibody
-
anti-B-Cell CLL/lymphoma 10 (BCL10) antibody
BCL10 Reactivity: Human WB, IHC, ELISA, FACS, ICC Host: Mouse Monoclonal 4F8 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 1-143) antibodyBCL10 Reactivity: Human WB, FACS, IHC (p) Host: Mouse Monoclonal 1185CT13-2-1-2 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 24-51), (N-Term) antibodyBCL10 Reactivity: Human, Mouse WB, IF, FACS, IHC (p) Host: Rabbit Polyclonal RB24271 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 98-234) antibodyBCL10 Reactivity: Human ELISA, FACS Host: Mouse Monoclonal 3C11F4 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 122-168) antibodyBCL10 Reactivity: Human WB, IHC, FACS, StM Host: Mouse Monoclonal BL10-411 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 122-168) antibodyBCL10 Reactivity: Human IHC, IF, FACS, StM Host: Rabbit Monoclonal BL10-2988R unconjugated Recombinant Antibody
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reactivity: Human, Dog WB, IHC, IHC (p) Host: Mouse Monoclonal 6A8 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reactivity: Human, Mouse, Rat WB, IHC, ELISA Host: Rabbit Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 1-233) antibodyBCL10 Reactivity: Human WB Host: Rabbit Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reactivity: Human, Mouse WB, IF, IHC (p), EIA Host: Mouse Monoclonal 4F8 unconjugated
-
- Application Notes
-
IHC(P): Dilution 1: 100- 1: 500
IHC(F): Dilution 1: 200- 1: 1000
Western blot: Dilution 1: 2000- 1: 5000
ELISA: Propose dilution 1: 10000.
Determining optimal working dilutions by titration test. - Restrictions
- For Research Use only
-
- Storage
- -20 °C
-
-
: "Vasoconstrictor responsiveness of portal hypertensive vessels." in: Clinical science (London, England : 1979), Vol. 96, Issue 1, pp. 3-4, (1999) (PubMed).
-
: "Vasoconstrictor responsiveness of portal hypertensive vessels." in: Clinical science (London, England : 1979), Vol. 96, Issue 1, pp. 3-4, (1999) (PubMed).
-
- Target
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
- Alternative Name
- BCL-10 (BCL10 Products)
- Background
- Bcl-10 is a 31kDa protein containing a caspase recruitment domain (CARD). It plays an important role in apoptosis and activating NF-kappaB. The research suggested that it interacted with other CARD domain containing proteins including CARD9, 10, 11 and 14, which were thought to function as upstream regulators in NF-kappaB signaling. Bcl10 is found to form a complex with MALT1 which encoded by another gene known to be translocated in MALT lymphoma. MALT1 and Bcl-10 are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy.
- Gene ID
- 8915
- Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteins
-
You are here:
